Stamos Capital Partners’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$5.84M Buy
74,654
+21,222
+40% +$1.71M 0.9% 39
2026
Q1
$4.63M Buy
53,432
+5,713
+12% +$547K 0.72% 46
2025
Q4
$4.58M Buy
47,719
+5,027
+12% +$488K 0.74% 41
2025
Q3
$4.07M Sell
42,692
-18,113
-30% -$1.67M 0.77% 35
2025
Q2
$5.3M Buy
60,805
+13,922
+30% +$1.18M 0.95% 28
2025
Q1
$4.21M Sell
46,883
-12,477
-21% -$1.12M 1.1% 23
2024
Q4
$4.74M Buy
59,360
+2,760
+5% +$239K 1.11% 22
2024
Q3
$5.1M Sell
56,600
-4,010
-7% -$337K 1.2% 23
2024
Q2
$4.77M Buy
60,610
+320
+0.5% +$26.2K 1.01% 25
2024
Q1
$5.25M Sell
60,290
-3,580
-6% -$306K 1.19% 19
2023
Q4
$5.26M Buy
63,870
+16,140
+34% +$1.23M 1.43% 18
2023
Q3
$3.74M Buy
47,730
+8,530
+22% +$714K 0.83% 29
2023
Q2
$3.45M Buy
39,200
+20,450
+109% +$1.76M 0.81% 31
2023
Q1
$1.51M Buy
+18,750
New +$1.53M 0.39% 69
2020
Q4
Sell
-2,500
Closed -$260K 65
2020
Q3
$260K Hold
2,500
0.1% 63
2020
Q2
$229K Sell
2,500
-8,768
-78% -$841K 0.13% 50
2020
Q1
$1.02M Buy
+11,268
New +$1.2M 0.54% 57
2019
Q1
Sell
-9,000
Closed -$819K 85
2018
Q4
$819K Buy
+9,000
New +$841K 0.62% 47

Other funds holding MDT

Stamos Capital Partners's MDT Position: Q2 2026 in Review

Stamos Capital Partners increased its Medtronic (MDT) stake by 40% in Q2 2026, buying an estimated $1.71M and bringing the position to 74,654 shares worth $5.84M. The position accounts for 0.9% of the portfolio, ranked #39.

Stamos Capital Partners first reported a position in MDT in Q4 2018 and has held it in 18 quarters since. 2,140 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Stamos Capital Partners held 74,654 shares of Medtronic worth $5.84M as of Q2 2026.
  • Stamos Capital Partners bought 21,222 Medtronic shares in Q2 2026, an estimated $1.71M.
  • Medtronic made up 0.9% of Stamos Capital Partners's portfolio in Q2 2026, its #39 holding.
  • Stamos Capital Partners first reported a position in Medtronic in Q4 2018 and has held it in 18 quarters since.
  • 2,140 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Stamos Capital Partners's 13F filing for Q2 2026, filed 13 Aug 2026.